Drug details

Zonisade (zonisamide oral suspension)

type of Anticonvulsants, Other

Zonisade (zonisamide oral suspension) is a carbonic anhydrase inhibitor indicated as adjunctive therapy for the treatment of partial-onset seizures in adults and pediatric patients 16 years of age and older.

This drug may have the following side effects:

• loss of appetite,
• dizziness,
• agitation,
• drowsiness,
• irritability, and
• problems with coordination and balance,
• difficulty with memory and/or concentration.

The following drugs are related to Zonisade, either as a replacement or used together:

• Briviact (brivaracetam oral solution and intravenous injection)
• Zarontin (ethosuximide)
• Zarontin Oral Solution (ethosuximide oral solution)
• Keppra (levetiracetam)
• Keppra Injection (levetiracetam)
• Keppra XR (levetiracetam extended-release tablets)
• Lamictal (lamotrigine)
• Lamictal XR (lamotrigine extended-release tablets)
• Roweepra Tablets (levetiracetam)
• Roweepra XR (levetiracetam extended-release tablets)
• Sabril (vigabatrin oral solution)
• Topamax (topiramate)
• Zonegran (zonisamide)